IGF-1 LR3 Made in USA — Third-Party Verified
Insulin-like Growth Factor-1 Long R3 (IGF-1 LR3) is a synthetic recombinant analogue engineered for extended bioactivity in preclinical research settings. Sourced directly through PX1 Research, our domestic synthesis ensures optimal structural integrity, batch-to-batch consistency, and rigorous analytical verification for laboratory applications.
Quick answer
Insulin-like Growth Factor-1 Long R3 (IGF-1 LR3) is a synthetic recombinant analogue engineered for extended bioactivity in preclinical research settings. Sourced directly through PX1 Research, our domestic synthesis ensures optimal structural integrity, batch-to-batch consistency, and rigorous analytical verification for laboratory applications.
Key takeaways
- [IGF-1 LR3](/research-peptides/igf-1-lr3) is an 83-amino-acid polypeptide analogue of human Insulin-like Growth Factor-1.
- When conducting sensitive cell culture assays or animal studies, sample purity and structural fidelity are critical parameters.
- Preclinical data indicate that [IGF-1 LR3](/research-peptides/igf-1-lr3) binds to the IGF-1R, a heterotetrameric transmembrane receptor tyrosine kinase.
- Understanding where [IGF-1 LR3](/research-peptides/igf-1-lr3) fits within the broader spectrum of growth factor research requires evaluating parallel compounds.
Structural Architecture and Design of IGF-1 LR3
IGF-1 LR3 is an 83-amino-acid polypeptide analogue of human Insulin-like Growth Factor-1. The modified sequence incorporates an arginine substitution for glutamic acid at position 3 (hence 'R3'), alongside a 13-amino-acid N-terminal extension peptide. This specific architectural alteration drastically reduces the peptide's affinity for endogenous Insulin-like Growth Factor Binding Proteins (IGFBPs), which normally sequester native IGF-1 and shorten its systemic half-life.
In cell culture and animal models, native IGF-1 exhibits a rapid clearance profile due to high-affinity binding to circulating IGFBPs. By preventing this sequestration, the LR3 modification allows a higher concentration of unbound peptide to interact directly with the Type 1 IGF Receptor (IGF-1R). Researchers evaluating cellular signaling kinetics frequently select this variant to establish prolonged receptor engagement without the confounding variable of rapid binder clearance in assay media.
The Strategic Value of USA Peptide Synthesis
When conducting sensitive cell culture assays or animal studies, sample purity and structural fidelity are critical parameters. Importing low-grade peptides from overseas suppliers often introduces risks such as truncated peptide sequences, residual TFA (trifluoroacetic acid) salts, and batch-to-batch potency variances. Sourcing USA-manufactured research peptides mitigates these confounding variables by enforcing strict quality control benchmarks throughout the solid-phase peptide synthesis (SPPS) and purification workflows.
At PX1 Research, domestic manufacturing takes place in state-of-the-art, cGMP-compliant facilities. Synthetic integrity is validated using modern automated synthesizers, ensuring accurate step-by-step residue coupling. For research institutions requiring consistent bulk supply, our wholesale lab procurement channels provide full traceability from initial synthesis to final packaging, guaranteeing that every vial conforms to precise analytical specifications.
Biochemical Mechanism of Action in Preclinical Models
Preclinical data indicate that IGF-1 LR3 binds to the IGF-1R, a heterotetrameric transmembrane receptor tyrosine kinase. Activation of IGF-1R triggers autophosphorylation of its intracellular kinase domain, creating docking sites for insulin receptor substrate (IRS) proteins. This event initiates two primary downstream intracellular signaling cascades: the Phosphoinositide 3-kinase (PI3K)-Akt pathway and the Mitogen-Activated Protein Kinase (MAPK/ERK) pathway.
In vitro assays demonstrate that activation of the PI3K-Akt axis downregulates apoptotic signaling and upregulates mammalian target of rapamycin (mTOR) signaling, a key driver of ribosomal biogenesis and protein translation. Concurrently, activation of the MAPK/ERK pathway stimulates cellular proliferation and differentiation. In rodent skeletal muscle models, researchers observe that sustained IGF-1R activation by IGF-1 LR3 accelerates satellite cell proliferation and enhances myotube hypertrophy compared to native IGF-1 controls.
Comparative Analysis: IGF-1 LR3, IGF-1 DES, and Growth Hormone Modulators
Understanding where IGF-1 LR3 fits within the broader spectrum of growth factor research requires evaluating parallel compounds. While IGF-1 LR3 is designed for extended half-life and systematic receptor engagement in vitro, truncated analogues like IGF-1 DES feature a 3-amino-acid N-terminal deletion that grants extreme receptor affinity specifically in localized, acidic tissue microenvironments. Conversely, splice variants like PEG-MGF operate downstream of mechanical tissue strain, focusing heavily on satellite cell recruitment rather than direct systemic metabolic modulation.
In contrast to direct recombinant growth factors, secretagogues such as CJC-1295 DAC or GHRP growth hormone secretagogues stimulate endogenous pituitary somatotroph release, producing pulsatile growth hormone surges that downstream elevate endogenous hepatic IGF-1. While secretagogues rely on intact neuroendocrine pathways, direct administration of high-purity IGF-1 LR3 allows investigators to bypass pituitary regulation entirely, isolating downstream signaling events in targeted tissue preparations.
Analytical Quality Assurance: ISO 17025 HPLC/MS Verification
To guarantee that experimental data remains reproducible, PX1 Research Subjects every production lot of IGF-1 LR3 to rigorous analytical testing in independent, ISO 17025 accredited laboratories. Primary verification relies on High-Performance Liquid Chromatography (HPLC) coupled with Mass Spectrometry (MS). HPLC analysis measures chromatographic purity, ensuring the target compound exhibits >98% purity with minimal sequence deletion or oxidation contaminants.
Mass spectrometry confirms the precise molecular weight of the 83-amino-acid chain, verifying structural identity. Furthermore, because bacterial contamination can severely distort cellular response assays, every lot undergoes chromogenic Limulus Amebocyte Lysate (LAL) testing to verify that endotoxin levels remain strictly below regulatory thresholds (<0.01 EU/μg). Lot-specific Certificates of Analysis (COAs) are accessible through our research peptide library for full verification prior to purchase.
Reconstitution, Handling, and Buffer Considerations for Lab Use
IGF-1 LR3 is supplied as a lyophilized (freeze-dried) sterile powder to ensure long-term stability during transport and storage. Proper reconstitution protocols must be followed to maintain peptide stability and prevent aggregation in laboratory setups. Reconstitution in plain sterile water or standard phosphate-buffered saline (PBS) is generally discouraged for long-term stock storage due to the peptide's propensity to adhere to glass or plastic container walls at neutral pH.
Standard laboratory protocols recommend reconstituting IGF-1 LR3 in a dilute acid solution, such as 10mM to 100mM acetic acid (pH ~2.5 to 3.0), to yield a stable stock solution. Once dissolved in dilute acid, the stock can be diluted into culture media or buffered solutions immediately prior to assay introduction. Reconstituted stock solutions should be aliquoted into polypropylene microcentrifuge tubes to avoid repeated freeze-thaw cycles and stored at -20°C or -80°C for optimal shelf life.
In Vitro Research Applications in Tissue Engineering
In tissue engineering and regenerative medicine studies, IGF-1 LR3 serves as a critical growth supplement in serum-free culture media. Researchers utilize the compound to study lineage commitment in mesenchymal stem cells (MSCs), cardiac progenitor differentiation, and chondrocyte matrix production. Due to its resistance to IGFBPs, low concentrations of IGF-1 LR3 can achieve biological responses equivalent to significantly higher doses of native IGF-1, reducing media cost and background variability.
In vitro models of metabolic signaling also utilize IGF-1 LR3 to examine glucose transport mechanisms. While IGF-1 primarily targets muscle and connective tissue, high-dose administration in cell culture models can reveal cross-reactivity with insulin receptors, helping scientists map receptor crosstalk in insulin-resistant cell lines or metabolic disease models.
Fulfillment and Logistics: Domestic Reliability from CA and AZ
Experimental timelines depend heavily on dependable reagent availability. PX1 Research eliminates international shipping delays, customs clearance seizures, and cold-chain breakdowns by managing fulfillment strictly within the United States. All products ship directly from our centralized distribution hubs located in California and Arizona.
Orders placed Monday through Friday before our daily cutoff are processed and shipped same-day. By utilizing temperature-controlled, secure packaging standards, PX1 Research maintains reagent integrity from our facility to your laboratory bench top.
Frequently Asked Questions
What makes IGF-1 LR3 different from standard native IGF-1?
IGF-1 LR3 contains an amino acid substitution (Arg for Glu at position 3) and a 13-amino-acid N-terminal extension. These structural modifications drastically reduce its binding affinity for IGF binding proteins (IGFBPs), prolonging its active half-life and availability in research media.
Where is PX1 Research IGF-1 LR3 synthesized?
All IGF-1 LR3 provided by PX1 Research is synthesized domestically in cGMP-compliant manufacturing facilities located in the USA, adhering to high purity standards.
How is the purity of IGF-1 LR3 verified?
Every lot undergoes independent, third-party analytical testing at an ISO 17025 accredited laboratory using High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) to verify molecular weight, identity, and purity levels exceeding 98%.
What are the endotoxin limits for PX1 Research peptides?
PX1 Research conducts kinetic chromogenic LAL assays on all lots. Endotoxin levels are verified to be below stringent thresholds (<0.01 EU/μg), making them suitable for sensitive cell culture and in vitro experiments.
How should lyophilized IGF-1 LR3 be stored upon delivery?
Lyophilized IGF-1 LR3 should be stored at -20°C or -80°C upon receipt. It should be kept desiccated and protected from light until reconstitution.
What solvent is recommended for reconstituting IGF-1 LR3 in the lab?
Laboratory guidelines generally recommend reconstituting IGF-1 LR3 in dilute acetic acid (10mM–100mM, pH 2.5–3.0) to prevent peptide aggregation and adhesion to tube walls, before diluting into working buffers.
What is the typical shipping timeline for laboratory orders?
Orders ship directly from our California or Arizona facilities. Orders placed Monday through Friday before cutoff are dispatched same-day.
Can IGF-1 LR3 be ordered in bulk for institutional research?
Yes, PX1 Research provides institutional accounts and bulk supply options. Inquiries for high-volume research quantities can be submitted via our wholesale portal.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.